Aclarion to enroll around 25% of patients in CLARITY trial by Q2
Aclarion, Inc. Common Stock · SERVICES-MEDICAL LABORATORIES · Now $3.37
-59% since the alert
$8.17 → $3.37
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS